Justin Chakma, Chief Business Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 302,760 shares at $8.86 ($2.7M) on 2025-11-12, disclosed to the SEC on 2025-11-14.
Open-market sale of $2.7M SPRY by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.86 | 136,380 | $1.2M | 45.0% |
| 2 | $8.86 | 136,380 | $1.2M | 45.0% |
| 3 | $8.91 | 30,000 | $267K | 10.0% |
| Total | $8.86 avg | 302,760 | $2.7M | 100% |
| Filing → |
| SPRY | SELL | 2024-12-06 | $2.7M | — | Filing → |
| SPRY | SELL | 2024-12-04 | $1.2M | — | Filing → |
| SPRY | SELL | 2024-11-27 | $2.0M | — | Filing → |